Medroxyprogesterone acetate stimulates cdk inhibitors, p21 and p27, in endometrial carcinoma cells transfected with progesterone receptor-B cDNA

European Journal of Gynaecological Oncology

Volumn 27, Issue 1, 2006, Pages 33-38

  Kawaguchi, M ^a   Watanabe, J ^b   Hamano, M ^b   Kamata, Y ^a   Arai, T ^a   Nishimura, Y ^a   Obokata, A ^a   Jobo, T ^b   Kuramoto, H ^a  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

FEndometrial carcinoma; Medroxyprogesterone acetate; p21; p27; Progesterone receptor

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR B; PROTEIN P21; PROTEIN P27;

ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENDOMETRIUM CANCER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ISHIKAWA CELL; PROTEIN EXPRESSION; TUMOR CELL CULTURE;

BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MEDROXYPROGESTERONE 17-ACETATE; RECEPTORS, PROGESTERONE; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33644965225     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ronnett B.M., Zaino, R.J., Ellenson L.H.: "Endometrial carcinoma". In: Kurman R.J. (ed.), Blaustein's Pathology of the Female Genital Tract, 5th edition. New York, Springer, 2002, 501.
2. Crissman J.D., Azoury R.S., Barnes A.E., Schellhas H.F.: "Endometrial cancer in women 40 years of age or younger". Obstet. Gynaecol., 1981, 57, 699.
3. Gallop D.G., Stock R.J.: "Adenocarcinoma of the endometrium in women 40 years of age or younger". Obstet. Gynecol., 1984, 64, 417.
4. Oshima A., Kuroishi T., Tajima T., "Cancer Statistics I Japan, (Mortality, Incidence and Survival)". Tokyo, Shinohara Shinsho. 2004.
5. Kelly R.M., Baker W.H.: "Progestational agents in the treatment of carcinoma of the endometrium". N. Engl. J. Med., 1961, 264, 216.
6. Kurman R.J., Kaminski P.F., Norris H.J.: "The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients". Cancer, 1985, 56, 403.
7. Randall T., Kurman R.: "Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in woman under age 40". Obstet. Gynecol., 1997, 90, 434.
8. Imai M., Jobo T., Sato R., Kawaguchi M., Kuramoto H.: "Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefullness and limitations". Eur. J Gynaecol. Oncol., 2001, 12, 217.
9. Smid-Kooppman E., Block L.J., Kuhne L.C.M., Burger C.W., Helmerhorst T.J.M., Brinkmann A.O. et. al.: "Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in tow endometrial carcinoma cell lines". J. Soc. Gynecol. Invest., 2003, 10, 49.
10. Polyak K., Lee M.H., Brobage H.E., Koff A., Roberts J.M., Tempst P. et. al.: "Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals". Cell, 1994, 78, 59.
11. Toyosima H., Hunter T.: "p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, Is related to p21". Cell, 1994, 78, 67.
12. Cheng J.D., Werness J.B., Babb J.S., Meropol N.J.: "Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma". Clin. Cancer Res., 1999, 5, 1057.
13. Kawana H., Tamaru J., Tanaka T., Hirai A., Sait Y., Kitagawa M., et. al.: "Role of p27Kip1 and cyclin-dependent kinase2 in the proliferation of non-small cell lung cancer". Am. J. Pathol., 1998, 153, 505.
14. Gillett C.E., Smith P., Peters G., Lu X., Barnes D.M.: "Cyclin-dependent kinase inhibitor P27Kip1 expression and interaction with other cell cyclin-associated proteins in mammary carcinoma". J. Pathol., 1999, 187, 200.
15. Masciullo V., Sgambato A., Pacilio C., Pucci B., Ferrandina G., Palazzo J., et. al.: "Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer". Cancer Res., 1999, 59, 3790.
16. Shamma A., Doki Y., Tsujinaka T., Shiozaki H., Inoue M., Yano M. et. al.: "Loss of p27KIP1 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma". Oncol., 2000, 58, 152.
17. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A. et. al.: "Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)". Mol. Endocrinol., 1997, 11, 1593.
18. Dai D., Wolf D.M., Litman E.S., White M.J., Leslie K.K.: "Progesterone inhibits human endometrial cancer cell growth and invasiveness: Down-regulation of cellular adhesion molecules through progesterone B receptors". Cancer Res., 2002, 62, 881.
19. Holinka C.F., Hata H., Kuramoto H., Gurpide E.: "Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa)". J. Steroid. Biochem., 1986, 25, 781.
20. Kuramoto H., Nishida M., Morisawa T., Hata H., Kato Y., Ohno E., Iida T. et. al.: "Establishment and characterization of human endometrial cancer cell lines". Ann. NY Acad. Sci., 1991, 622, 402.
21. Nishida M., Ishikawa Cells: "Opening of in vitro hormone research on endometrial carcinoma". Cell and Molecular Biology of Endometrial Carcinoma, Kuramoto H. and Nishida M. (eds.), Tokyo, Springer, 2003, 35.
22. Kumar N.S., Richer J., Owen G., Litman E., Horwitz K.B., Leslie K. K.: "Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action". Cancer Res., 1998, 58, 1860.
23. Lacroix M., Leclercq G.: "Relevance of breast cancer cell lines as models for breast tumors: An update". Breast Cancer Res. Treat., 2004, 83, 249.
24. De-Ding T., Min J., Jan-Hong W., Yong-Dong F., Jian-Ping G.: "Western blot analysis and flow cytmetric analysis of estrogen and progesterone receptors in fixed breast cancer cells". Chinese J. Cancer, 2004, 23, 339.
25. Clarke C.L., Sutherland R.L.: "Progestin regulation of cellular proliferation". Endocr. Rev., 1990, 11, 266.
26. Lin V.C.L., Ng E.H., Aw S.E., Tan M.G.K., Ng E.H.L., Chan V.S.W. et. al.: "Progestestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA". Clin. Cancer Res., 1999, 5, 395.
27. Thuneke I., Schulte H.M., Bamberger A.M.: "Biphasic effect of medroxyprogesterone acetate treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells". Breast Cancer Res. Treat., 2000, 63, 243.
28. Tong W., Pollard J.W.: "Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice". Mol. Cell. Biol., 1999, 19, 2251.
29. Shiozawa T., Nikaido T., Nakayama K., Lu X., Fujii S.: "Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of the endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone". Mol. Human Reprod., 1998, 4, 899.
30. Watanabe J., Sato H., Kanai T., Kamata Y., Jobo T., Hata H. et. al.: "Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corps - correlation with proliferation an clinicopathological parameters". Br. J. Cancer, 2002, 87, 81.
31. Musgrove E.A., Swarbrick A., Lee C.S., Cornish A., Sutherl R.L.: "Mechanisms of cyclin-dependent kinase inactivation by progestins". Mol. Cell. Biol., 1998, 18, 1812.
32. Lin V.C.L., Woon C.T., AW S.E., Guo C.: "Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion". Endocrinology, 2003, 144, 5650.
33. Kester H.A., Sonneveld E., Saag P.T.V.D., Bur B.V.D.: "Prolonged progestin treatment induces the promoter of CDK inhibitor p21Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells". Exp. Cell. Res., 2003, 284, 264.
34. Sherr C.J., Roberts J.M.: "CDK inhibitors: positive and negative regulators of G1-phase progression". Gene. Develop., 1999, 13, 1501.
35. Musgrove E.A., Hamilton J.A., Lee C.S.L., Sweeney K.J.E., Watts C.K.W., Sutherland R.L.: "Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression". Mol. Cell. Biol. 1993, 13, 3577.
36. Musgrove E.A., Lee C.S.L, Buckley M.F., Sutherland R.L.: "Cyclin D1 induction in breast cancer cell shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle". Proc. Natl. Acad. Sci. USA, 1994, 91, 8022.